The "next-generation" knowledge of papillary thyroid carcinoma

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Papillary thyroid carcinoma (PTC) genetics are complex, with some cases lacking identified driver mutations.
• Gene and microRNA (miRNA) expression patterns are linked to PTC progression and clinical subclasses.
• Existing classifications may not fully capture the molecular heterogeneity of PTC.

Purpose of the Study:

• To investigate novel genetic alterations in PTC using Next-Generation Sequencing.
• To correlate gene and miRNA expression profiles with distinct molecular subclasses of PTC.
• To propose a revised classification scheme for PTC based on molecular findings.

Main Methods:

• Application of Next-Generation Sequencing to identify somatic mutations and gene fusions in PTC.
• Gene and miRNA expression profiling to define molecular subclasses.
• Comparative analysis of genomic, epigenomic, and proteomic profiles between different PTC categories.

Main Results:

• New somatic mutations and gene fusions were identified as potential tumor-initiating events in PTC.
• Distinct gene and miRNA expression profiles correlate with tumor progression and clinically relevant subclasses.
• "BRAF-like" carcinomas (BRAF mutations, RET rearrangements) show a unique expression pattern.
• "RAS-like" carcinomas exhibit different genomic, epigenomic, and proteomic characteristics.

Conclusions:

• Next-Generation Sequencing has uncovered new genetic drivers in PTC.
• PTC can be molecularly classified into distinct categories like "BRAF-like" and "RAS-like" based on expression patterns.
• These findings necessitate a reconsideration of current PTC classification systems.